Screening for Atrial Fibrillation and Hypertension: Time to Act Now
Published: 17 October 2024
-
Views:
13376 -
Likes:
7
-
Views:
13376 -
Likes:
7
-
6m 29sPart 3 | Session 1 Hypertension and Atrial Fibrillation: Dangerous Bedfellows
-
10m 48sPart 3 | Session 2 Screening for Hypertension and AF in One Go: A No-brainer
-
10m 30sPart 3 | Session 3 Changing the Game for New AF Screening Initiatives
-
7m 10sPart 3 | Session 4 AF and its Pulse Wave: A New Footprint
-
14m 29sPart 3 | Session 5 Discussion and Q&A
Overview
This video series offers a comprehensive exploration of the latest advancements in the management of hypertension and atrial fibrillation (AF) as presented at ESC 2024 in London. Experts reflect on key updates to the guidelines, examining their impact on clinical practice, with a particular emphasis on gender-specific considerations. The series also delves into the critical relationship between hypertension and AF, highlighting the importance of home-based screening and introducing viewers to the latest innovations in AF detection technology.
For more information visit the Omron Academy following the link here.
Learning Objectives
- To be familiar with the relation between hypertension and AF
- To understand the importance of screening for AF and hypertension at home
- To know the latest insights on AF detection innovations
- To understand the risk of stroke in undiagnosed AF
Target Audience
- Electrophysiologists
- Interventional Cardiologists
- Heart Failure Specialists
- General Practitioners With a Special Interest in Cardiology
More from this programme
Part 1
Heart 2 Heart
Prof Alta Schutte and Prof Renate Schnabel provide an in-depth analysis of the recently presented guidelines for hypertension and AF unveiled at the ESC 2024.
Part 2
Gender Matters
Prof Alta Schutte and Prof Renate Schnabel discuss the hypertension and AF guidelines released at ESC 2024, with a focus on gender-specific considerations.
Part 3
ESC Symposium – Screening for AF and Hypertension: Time to Act Now
In this symposium from ESC 2024 in London, faculty explore the connection between hypertension and AF. They discuss the importance of home-based screening for both conditions and discover the latest innovations in AF detection.
Faculty Biographies
Renate Schnabel
Consultant in Cardiology
Renate Schnabel is a consultant in cardiology at University Heart Centre Hamburg, Germany. She graduated from medical school in Mainz, Germany in 2002. After a research fellowship at the Framingham Heart Study, Boston University, she moved to Hamburg. She works with clinical and population cohorts and leads national and EU-funded international consortia. She is PI of the German Centre for Cardiovascular Research. Her research interest is in digital cardiology, atrial fibrillation and heart failure, and omics for cardiovascular risk assessment. Very active within professional organizations, she is member on councils of the European Society of Cardiology, American Heart Association and the German Cardiac Society.
Alta Schutte
Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine
Prof Alta Schutte is Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine at the University of New South Wales, Sydney, Australia; with a joint appointment as Professorial Fellow at the George Institute for Global Health. She has extensive experience in working in the field of hypertension and cardiovascular disease with approx. 450 publications in the field. She serves as Editor of the AHA Journal, Hypertension and is on the Editorial Board of several cardiovascular journals, such as Hypertension, the Journal of Hypertension, Journal of Clinical Hypertension, Journal of Human Hypertension, Current Hypertension Reports and BMC Medicine. She is a Fellow of the European Society of Cardiology, the International Society of Hypertension (ISH) and the Royal Society of South Africa; the Past President of the Southern African Hypertension Society (SAHS); and Past President of the International Society of Hypertension.
Ben Freedman
Director of External Affairs
Prof Ben Freedman is currently Director External Affairs at the Heart Research institute and Group Leader of its Heart Rhythm and Stroke Prevention Group.
He is a Honorary Professor of Cardiology at the University of Sydney and former head of Department of Cardiology, Concord Hospital.
In 2015 with five others he formed the AF SCREEN International Collaboration, which now has well over 2,000 members from 40 countries, including many of the foremost names in atrial fibrillation (AF) research. He has chaired the group in four important white papers/Frontiers Reviews on screening for AF to prevent stroke published in Circulation, the premier journal of the American Heart Association.